Biotech Bombshell: BioMarin's $4.8B Bet Ignites Amicus Shares in Rare-Disease Power Play [Yahoo! Finance]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: Yahoo! Finance
Inc. ( NASDAQ:FOLD ) in a transaction valued at about $4.8 billion, a move that could strengthen BioMarin's position in rare-disease treatments. Under the terms, Amicus shareholders are set to receive $14.50 per share in cash, representing a 33% premium to the prior closing price, with the deal expected to close in the second quarter of 2026 subject to shareholder and regulatory approvals. The market response was swift, with Amicus shares jumping 31% in early New York trading and BioMarin rising 15%, marking their strongest single-day gains in years. Warning! GuruFocus has detected 8 Warning Signs with ARES. Is BMRN fairly valued? Test your thesis with our free DCF calculator. BioMarin Chief Executive Officer Alexander Hardy said the transaction makes strategic sense given BioMarin's commercial footprint and manufacturing capabilities, particularly as both companies focus on lysosomal storage disorders. The acquisition would give BioMarin access to approved treatments for Fabry
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical Inc. (BMRN) M&A Call Transcript [Seeking Alpha]Seeking Alpha
- BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping. [Yahoo! Finance]Yahoo! Finance
- BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping. [Barron's]Barrons
- BioMarin Pharmaceutical to Acquire Amicus Therapeutics in $4.8 Billion Deal [Yahoo! Finance]Yahoo! Finance
BMRN
Earnings
- 10/27/25 - Miss
BMRN
Sec Filings
- 12/19/25 - Form 8-K
- 12/17/25 - Form 8-K
- 12/2/25 - Form 4
- BMRN's page on the SEC website